Adalid Sciences Co-Founder and CSO Petr Cigler Honored with the Rudolf Lukes Prize

We are thrilled to announce that our Chief Scientific Officer and Co-Founder, Petr Cigler, Ph.D., has been awarded the prestigious 2025 Rudolf Lukes Prize. Presented by the Czech Chemical Society in cooperation with the Experientia Foundation, this award is reserved for scientists whose original work has fundamentally moved the needle in the field of organic chemistry.

The Science Behind the Award

The international committee recognized Petr for his pioneering work in synthetic nanochemistry—specifically, his development of sophisticated nanoparticle systems that act as a bridge between synthetic chemistry and biological environments.

This isn't just about laboratory success; it's about solving the "delivery problem" in modern medicine. Petr’s research has led to:

• Next-Generation Lipid Nanoparticles: Creating safer, more efficient vehicles for delivering nucleic acids into cells—the backbone of gene therapy and advanced vaccines.
• Quantum-Grade Nanodiamonds: Developing ultra-stable optical probes that allow for non-invasive imaging and diagnostics with unprecedented precision.
• Targeted Therapeutics: Designing nanoparticles that can selectively block growth factors to treat autoimmune disorders and cancer.

From the Lab to the Market

At Adalid Sciences, we believe that the best science should never stay confined to a journal. The very innovations that earned Petr the Rudolf Lukeš Prize are the engine behind Adalid’s mission.

By commercializing these "Adalids" (champions) of the molecular world, we are turning award-winning research into tangible solutions for gene medicine, oncology, and precision diagnostics.

"The Rudolf Lukeš Prize is a profound honor that validates the importance of interdisciplinary chemistry. At Adalid Sciences, we are taking these molecular tools and applying them to the most pressing challenges in human health." — Petr Cígler, CSO

‍